Matthew Goff Investment Advisor LLC Has $6.80 Million Holdings in The Procter & Gamble Company (NYSE:PG)

Matthew Goff Investment Advisor LLC lowered its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 0.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 41,882 shares of the company’s stock after selling 107 shares during the period. Procter & Gamble makes up approximately 1.4% of Matthew Goff Investment Advisor LLC’s holdings, making the stock its 23rd biggest position. Matthew Goff Investment Advisor LLC’s holdings in Procter & Gamble were worth $6,795,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Wellington Management Group LLP increased its stake in shares of Procter & Gamble by 9.4% in the third quarter. Wellington Management Group LLP now owns 35,608,913 shares of the company’s stock worth $5,193,916,000 after purchasing an additional 3,047,557 shares during the period. Norges Bank bought a new position in shares of Procter & Gamble in the fourth quarter worth about $3,956,117,000. Charles Schwab Investment Management Inc. increased its stake in shares of Procter & Gamble by 1.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 16,209,425 shares of the company’s stock worth $2,336,552,000 after purchasing an additional 206,165 shares during the period. Royal Bank of Canada increased its stake in shares of Procter & Gamble by 3.2% in the third quarter. Royal Bank of Canada now owns 11,170,305 shares of the company’s stock worth $1,629,299,000 after purchasing an additional 346,925 shares during the period. Finally, Fisher Asset Management LLC increased its stake in shares of Procter & Gamble by 5.6% in the fourth quarter. Fisher Asset Management LLC now owns 10,556,988 shares of the company’s stock worth $1,547,021,000 after purchasing an additional 559,358 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Transactions at Procter & Gamble

In other news, CEO R. Alexandra Keith sold 855 shares of the business’s stock in a transaction that occurred on Monday, April 22nd. The stock was sold at an average price of $158.50, for a total value of $135,517.50. Following the transaction, the chief executive officer now directly owns 4,004 shares of the company’s stock, valued at approximately $634,634. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Procter & Gamble news, insider Balaji Purushothaman sold 28,369 shares of the company’s stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the transaction, the insider now owns 11,507 shares of the company’s stock, valued at approximately $1,858,265.43. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO R. Alexandra Keith sold 855 shares of the company’s stock in a transaction on Monday, April 22nd. The stock was sold at an average price of $158.50, for a total value of $135,517.50. Following the transaction, the chief executive officer now directly owns 4,004 shares in the company, valued at approximately $634,634. The disclosure for this sale can be found here. Insiders have sold 154,544 shares of company stock valued at $25,413,051 in the last three months. 0.17% of the stock is owned by corporate insiders.

Procter & Gamble Price Performance

Shares of PG traded up $0.59 on Friday, hitting $168.26. The company’s stock had a trading volume of 14,682,061 shares, compared to its average volume of 5,021,979. The company has a market capitalization of $397.12 billion, a PE ratio of 27.49, a PEG ratio of 3.40 and a beta of 0.42. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.69 and a quick ratio of 0.48. The Procter & Gamble Company has a fifty-two week low of $141.45 and a fifty-two week high of $168.97. The company has a 50 day moving average price of $164.59 and a 200 day moving average price of $158.09.

Procter & Gamble (NYSE:PGGet Free Report) last announced its earnings results on Friday, April 19th. The company reported $1.52 EPS for the quarter, topping the consensus estimate of $1.42 by $0.10. The business had revenue of $20.20 billion for the quarter, compared to the consensus estimate of $20.43 billion. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. Procter & Gamble’s revenue was up .6% compared to the same quarter last year. During the same period in the previous year, the business earned $1.37 EPS. On average, research analysts anticipate that The Procter & Gamble Company will post 6.55 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th were issued a $1.0065 dividend. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 annualized dividend and a dividend yield of 2.39%. The ex-dividend date was Thursday, April 18th. Procter & Gamble’s payout ratio is presently 65.85%.

Analyst Ratings Changes

PG has been the topic of a number of recent analyst reports. Argus lifted their price objective on Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a research note on Thursday, April 25th. Deutsche Bank Aktiengesellschaft lowered their price target on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating on the stock in a research note on Monday, April 22nd. Barclays boosted their price target on Procter & Gamble from $168.00 to $170.00 and gave the company an “overweight” rating in a research note on Tuesday, April 23rd. StockNews.com lowered Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Monday, June 17th. Finally, The Goldman Sachs Group initiated coverage on Procter & Gamble in a research note on Friday, March 1st. They set a “neutral” rating and a $168.00 price target on the stock. Seven equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $169.76.

Get Our Latest Report on PG

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.